Pharma & Biotech

A major legal overhang for the telehealth company Hims & Hers has been decisively removed, sending its shares skyrocketing. The...

A notable surge in institutional investment is signaling strong market confidence in Gilead Sciences. The biopharmaceutical giant is attracting significant...

Investor attention within the biotechnology space is increasingly focused on Outlook Therapeutics. The company is approaching several pivotal operational milestones...

The medical technology firm Strata Skin Sciences is moving to formally terminate its status as a publicly traded company. This...

Following the full integration of Progressive Care, NextPlat Corp. is expressing confidence in its operational trajectory for the coming periods....

Axsome Therapeutics is entering a pivotal phase of commercial growth, with plans to significantly scale its operations and await a...

The operational journey of Ampio Pharmaceuticals is nearing its conclusion. The company has shifted its focus entirely to executing an...

Within the fast-paced biotechnology landscape, Denali Therapeutics continues to command investor attention. The company's trajectory is being shaped by a...

Facing the impending loss of patent protection for its key immunology drug Stelara, Johnson & Johnson is strategically bolstering its...

The investment case for Swiss pharmaceutical giant Roche presents a complex picture, marked by promising clinical developments in one area...